A company developing needle-free vaccination tech just raised $25 million

chevron_leftPreviosly
Nanopatch vaccine technology company attracts $25 million
10 February 2015
Nextchevron_right
Vaxxas raises $25m in Series B financing
10 February 2015

You may also like

10 November 2021

Victorian startups will soon be able to pitch themselves to one of Australia’s leading VC firms as part of a $30 million government initiative

10 March 2016

Forget unicorns: ‘Dragons’ are the Australian startup problem no one’s talking about

04 December 2017

“As big as the internet”: Why this venture capitalist says blockchain technology and “cryptoassets” are the future of fintech

10 February 2015

A company developing needle-free vaccination tech just raised $25 million

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor
clear Close